Teriparatide transdermal (Zosano Pharma)
特立帕肽透皮系统
Report date: 2022/07/04 19:38:02
Base Information
Drug NameTeriparatide transdermal (Zosano Pharma)
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesZosano Pharma Corp
China Registration ClassN/A
Develop Information
Active CompaniesEli Lilly And CompanyShinshu University
Inactive CompaniesZosano Pharma Corp
Active Indications
Inactive Indications